Direct-to-consumer (DTC) genetic testing refers to genetic tests or services that are directly advertised to consumers and purchased through consumer’ requests. The results of these tests are directly provided to consumers/customers without any participation of the consumers’ health care providers. This type of genetic test is directly marketed to customers/consumers by using print advertisements, television, or the Internet. Many medical device companies are marketing this DTC testing to the public at a realistic price point without consulting with doctors or other medical professionals. Consumers can order genetic testing kits from home by using a website and receive volumes of information relating to their individual genetic profile without visiting a doctor.
The DTC genetic testing market contains two business models: one-to-one and one-to-many. In the one-to-one model, the results are discussed directly by the companies with the consumer or with the physician. In the one-to-many model, DTC companies will only conduct a genetic test once they receive consent from the consumer and the data is owned by the companies. The companies operating in this market obtain profit from the sales of DTC genetic testing kits to consumers and physicians and the sales of genetic data to pharmaceutical companies. This paradigm shift in business models is identified as one of the key trends behind the growth of the DTC genetic testing market.
The global DTC genetic testing market is expected to grow substantially due to high aging population coupled with growing prevalence of chronic disorders such as type 2 diabetes, cardiovascular diseases (CVDs), diabetic retinopathy, and other chronic diseases. In addition, growing customer awareness about direct-to-consumer genetic testing, along with increasing prevalence of major chronic diseases has resulted in rise in healthcare expenditure and the demand of DTC genetic testing is increase for early diagnosis various diseases are fuel the growth of the direct- to- consumer genetic testing market. However, DTC genetic testing raises a number of issues, including scientific, technical, and clinical issues, along with First Amendment issues of honesty, fidelity to facts, and truth-in-advertising, are limiting the growth of the global market.
The global DTC genetic testing market is segmented based on service, distribution channel, and region. In terms of service, the market is further segmented into diagnostic screening, prenatal, newborn screening, pre-implantation diagnosis, and relationship testing. The diagnostic screening segment dominates the global DTC genetic testing market as it helps in identifying the gene responsible for chronic diseases such as cancer. This includes carrier screening and hereditary testing that are usually conducted for DTC genetic testing. In terms of distribution channel, the market is classified into direct sales, retail sales, and laboratory sales. The direct sales segment generates high revenue due to pricing strategies.
Geographically, the DTC genetic testing market is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each geography market is sub-divided into specific countries such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC countries. North America dominated global DTC genetic testing market because of importance of early diagnosis of for better treatment outcomes, and high level of consumer literacy about diseases. Asia Pacific is projected to be the most attractive market during the forecast period due to rising health care awareness and growing disposable income.
Key players operating in this market are 23andMe, Inc., Laboratory Corporation of America, Myriad Genetics, Inc., Quest Diagnostics, Counsyl, Inc., Gene by Gene, and Positive Bioscience Ltd. In order to gain competitive advantage in the market, these market players are actively involved in various growth strategies such as collaborations, partnerships, agreements, and new product launches.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.